Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 310,521 | 298,513 | 258,991 | 266,619 | 271,298 |
| Cost of Goods | 59,020 | 56,358 | 47,674 | 46,059 | 47,289 |
| Gross Profit | 251,501 | 242,155 | 211,317 | 220,560 | 224,009 |
| Operating Expenses | 198,983 | 197,158 | 172,405 | 181,607 | 179,727 |
| Operating Income | 52,538 | 45,355 | 39,586 | 39,012 | 44,571 |
| Interest Expense | -1,108 | 1,377 | 217 | 21 | 22 |
| Other Income | 885 | 297 | 610 | 172 | 1,253 |
| Pre-tax Income | 54,531 | 44,275 | 39,979 | 39,163 | 45,802 |
| Income Tax | 14,902 | 13,769 | 12,002 | 12,611 | 15,048 |
| Net Income Continuous | 39,629 | 30,506 | 27,977 | 26,552 | 30,754 |
| Net Income | $39,629 | $30,506 | $27,977 | $26,552 | $30,754 |
| EPS Basic Total Ops | 1.87 | 1.45 | 1.33 | 1.24 | 1.40 |
| EPS Basic Continuous Ops | 1.88 | 1.45 | 1.33 | 1.24 | 1.40 |
| EPS Diluted Total Ops | 1.87 | 1.44 | 1.32 | 1.23 | 1.40 |
| EPS Diluted Continuous Ops | 1.87 | 1.44 | 1.32 | 1.23 | 1.39 |
| EBITDA(a) | $58,055 | $50,948 | $45,236 | $44,761 | $50,296 |